124 related articles for article (PubMed ID: 9037176)
1. Liposome-mediated DNA vaccination.
Gregoriadis G; Saffie R; de Souza JB
FEBS Lett; 1997 Feb; 402(2-3):107-10. PubMed ID: 9037176
[TBL] [Abstract][Full Text] [Related]
2. Liposome-mediated DNA vaccination: the effect of vesicle composition.
Perrie Y; Frederik PM; Gregoriadis G
Vaccine; 2001 Apr; 19(23-24):3301-10. PubMed ID: 11312029
[TBL] [Abstract][Full Text] [Related]
3. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
4. Immunoadjuvant action of plasmid DNA in liposomes.
Gürsel M; Tunca S; Ozkan M; Ozcengiz G; Alaeddinoglu G
Vaccine; 1999 Mar; 17(11-12):1376-83. PubMed ID: 10195773
[TBL] [Abstract][Full Text] [Related]
5. Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complex.
Wang J; Hu JH; Li FQ; Liu GZ; Zhu QG; Liu JY; Ma HJ; Peng C; Si FG
Exp Dermatol; 2007 Sep; 16(9):724-9. PubMed ID: 17697144
[TBL] [Abstract][Full Text] [Related]
6. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
Schirmbeck R; Reimann J
Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
[TBL] [Abstract][Full Text] [Related]
7. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
[TBL] [Abstract][Full Text] [Related]
8. Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen.
Bramwell VW; Eyles JE; Somavarapu S; Alpar HO
Immunology; 2002 Jul; 106(3):412-8. PubMed ID: 12100730
[TBL] [Abstract][Full Text] [Related]
9. A role for liposomes in genetic vaccination.
Gregoriadis G; Bacon A; Caparros-Wanderley W; McCormack B
Vaccine; 2002 Dec; 20 Suppl 5():B1-9. PubMed ID: 12477411
[TBL] [Abstract][Full Text] [Related]
10. Liposome (Lipodine)-mediated DNA vaccination by the oral route.
Perrie Y; Obrenovic M; McCarthy D; Gregoriadis G
J Liposome Res; 2002; 12(1-2):185-97. PubMed ID: 12604053
[TBL] [Abstract][Full Text] [Related]
11. Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
Dutta T; Garg M; Jain NK
Vaccine; 2008 Jun; 26(27-28):3389-94. PubMed ID: 18511160
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
13. Surface modified liposomes for nasal delivery of DNA vaccine.
Khatri K; Goyal AK; Gupta PN; Mishra N; Mehta A; Vyas SP
Vaccine; 2008 Apr; 26(18):2225-33. PubMed ID: 18396362
[TBL] [Abstract][Full Text] [Related]
14. [Construction of eukaryotic expression plasmids inserting HBsAg gene and DNA immunization responses to HBsAg in mice].
Liang Z; Lan Y; Li Y; Cai D; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):106-8. PubMed ID: 11983125
[TBL] [Abstract][Full Text] [Related]
15. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
[TBL] [Abstract][Full Text] [Related]
16. DNA-mediated immunization of mice with plasmid encoding HBs antigen.
Yoon SJ; Park JW; Ahn SY; Choe BK; Suh MH
J Korean Med Sci; 1999 Apr; 14(2):187-92. PubMed ID: 10331566
[TBL] [Abstract][Full Text] [Related]
17. Induction of immunity against hepatitis B virus surface antigen by intranasal DNA vaccination using a cationic emulsion as a mucosal gene carrier.
Kim TW; Chung H; Kwon IC; Sung HC; Kang TH; Han HD; Jeong SY
Mol Cells; 2006 Oct; 22(2):175-81. PubMed ID: 17085969
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of a plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapse.
Triozzi PL; Aldrich W; Allen KO; Carlisle RR; LoBuglio AF; Conry RM
J Immunother; 2005; 28(4):382-8. PubMed ID: 16000957
[TBL] [Abstract][Full Text] [Related]
19. Enhanced adjuvanticity of interleukin-2 plasmid DNA administered in polyethylenimine complexes.
Oh YK; Park JS; Kang MJ; Ko JJ; Kim JM; Kim CK
Vaccine; 2003 Jun; 21(21-22):2837-43. PubMed ID: 12798625
[TBL] [Abstract][Full Text] [Related]
20. Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approach.
Shrivastava S; Lole KS; Tripathy AS; Shaligram US; Arankalle VA
Vaccine; 2009 Nov; 27(47):6582-8. PubMed ID: 19747579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
